183 related articles for article (PubMed ID: 6141975)
1. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
[TBL] [Abstract][Full Text] [Related]
4. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
[No Abstract] [Full Text] [Related]
5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
6. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
8. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
Lambertz H; Meyer J; Erbel R
Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
[TBL] [Abstract][Full Text] [Related]
9. Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine.
Tangø M; Trap-Jensen J; Rehling M; Jespersen C; Lyngborg K
Dan Med Bull; 1988 Feb; 35(1):75-8. PubMed ID: 3125010
[TBL] [Abstract][Full Text] [Related]
10. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
Oltmanns D; Wester HA; Stein R
Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
12. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
[TBL] [Abstract][Full Text] [Related]
13. Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failure.
Peng Y; Shan J; Qi X; Xue H; Rong C; Yao D; Guo Z; Zheng S
Chin Med J (Engl); 2003 Oct; 116(10):1459-63. PubMed ID: 14570600
[TBL] [Abstract][Full Text] [Related]
14. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Rae AP; Tweddel AC; Hutton I
Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
[TBL] [Abstract][Full Text] [Related]
16. [Beta-adrenergic stimulation with prenalterol in sick sinus syndrome].
Treese N; Russ M; Kasper W; Meinertz T; Pop T
Z Kardiol; 1983 Aug; 72(8):481-6. PubMed ID: 6624189
[TBL] [Abstract][Full Text] [Related]
17. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
Chu KM; Shieh SM; Hu OY
Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
